Announcements Trials
Browse Landscape

Status

Terminated 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 3Observational 2Expanded_access 1

Sponsor

Cancer Type

Sarcoma 2

Conditions

Osteosarcoma 2

Interventions

Blood Specimen Collection 4Drug Therapy 3mifamurtide 2Surveys and Questionnaires 2Psychiatric Rehabilitation 2Patient Reported Outcome Measures 2Methotrexate 2glucarpidase 1X-Rays 1Weight-Bearing 1Tomography, X-Ray Computed 1Therapeutics 1Surgical Procedures, Operative 1Specimen Handling 1Reverse Transcriptase Polymerase Chain Reaction 1Range of Motion, Articular 1Radiotherapy 1Quality of Life 1Positron-Emission Tomography 1Polymerase Chain Reaction 1Molecular Diagnostic Techniques 1Microbiota 1Microarray Analysis 1Metabolome 1Medical Records 1Magnetic Resonance Imaging 1In Situ Hybridization, Fluorescence 1Immunotherapy 1HMPL-013 1Gene Rearrangement 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Osteosarcoma × mifamurtide × Clear all
NCT01194284 2017-01-19

Surveillance Study of Patients With Newly Diagnosed Osteosarcoma

Takeda

Terminated
25 enrolled
Sarcoma

Osteosarcoma

NCT00631631 2014-05-14

Mifamurtide (L-MTP-PE) for High-Risk Osteosarcoma

Millennium Pharmaceuticals, Inc.

Completed
205 enrolled
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡